S Michael Phillips MD
Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3737 Market St3rd FloorPhiladelphia, PA 19104
Phone+1 215-662-2775
Dr. Phillips is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1969 - 1972
University of Pennsylvania Health SystemResidency, Internal Medicine, 1966 - 1969
University of Wisconsin School of Medicine & Public HealthClass of 1966
Certifications & Licensure
PA State Medical License 1975 - 2022
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1980
Publications & Presentations
PubMed
- 1 citationsIs oral isotretinoin treatment contraindicated for patients with known peanut allergiesVictoria S. Humphrey, S. Michael Phillips, William D. James
JAAD Case Reports. 2020-01-16 - 2 citationsDAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice.Mahendra K. Bhopale, Brendan Hilliard, Cris S. Constantinescu, S. Michael Phillips, Abdolmohamad Rostami
Immunopharmacology and Immunotoxicology. 2017-09-20 - 3 citationsDAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.Mahendra K. Bhopale, Brendan Hilliard, Cris S. Constantinescu, Toshiki Fujioka, Elvira Ventura
Experimental and Molecular Pathology. 2014-02-01
Grant Support
- Suppression Of Immunopathology In Schistosmiasis By AntiNational Institute Of Allergy And Infectious Diseases2000–2001
- S Mansoni Vitellogenesis And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1996–1999
- Suppression Of Immunopathology In Schistosomiasis By DABNational Institute Of Allergy And Infectious Diseases1994–1997
- S. Mansoni Vitellogenesis And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1989–1993
- S. Mansoni Vitellogenesis And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1989–1991
- In Vitro S. Mansoni Fecundity And Granuloma FormationNational Institute Of Allergy And Infectious Diseases1985–1988
- The Idiotypic Regulation Of Resistance To SchistosomiasiNational Institute Of Allergy And Infectious Diseases1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
